Version 2024

2024 ICD-10-CM Diagnosis Code C50.12

Malignant neoplasm of central portion of breast, male

ICD-10-CM Code:
C50.12
ICD-10 Code for:
Malignant neoplasm of central portion of breast, male
Is Billable?
Not Valid for Submission
Code Navigator:

Code Classification

  • Neoplasms
    (C00–D49)
    • Malignant neoplasms of breast
      (C50)
      • Malignant neoplasm of breast
        (C50)

C50.12 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of malignant neoplasm of central portion of breast, male. The code is not specific and is NOT valid for the year 2024 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.

The following anatomical sites found in the Table of Neoplasms reference the parent code C50.1 of the current diagnosis code given the correct histological behavior: Neoplasm, neoplastic breast (connective tissue) (glandular tissue) (soft parts) central portion .

Specific Coding Applicable to Malignant neoplasm of central portion of breast, male

Non-specific codes like C50.12 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10-CM codes with a higher level of specificity when coding for malignant neoplasm of central portion of breast, male:

  • Use C50.121 for Malignant neoplasm of central portion of right male breast - BILLABLE CODE

  • Use C50.122 for Malignant neoplasm of central portion of left male breast - BILLABLE CODE

  • Use C50.129 for Malignant neoplasm of central portion of unspecified male breast - BILLABLE CODE

Table of Neoplasms

The parent code C50.1 of the current diagnosis code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»Neoplasm, neoplastic
  »breast (connective tissue) (glandular tissue) (soft parts)
    »central portion
C50.1C79.81D05.D24.D48.6D49.3

Patient Education


Male Breast Cancer

Although breast cancer is much more common in women, men can get it too. It happens most often to men between the ages of 60 and 70.

Breast lumps usually aren't cancer. However, most men with breast cancer have lumps. Other breast symptoms can include:

  • Dimpled or puckered skin
  • A red, scaly nipple or skin
  • Fluid discharge

Risk factors for male breast cancer include exposure to radiation, a family history of breast cancer, and having high estrogen levels, which can happen with diseases like cirrhosis or Klinefelter syndrome.

Treatment for male breast cancer is usually a mastectomy, which is surgery to remove the breast. Other treatments include radiation, chemotherapy and/or hormone therapy.

NIH: National Cancer Institute


[Learn More in MedlinePlus]

Male Breast Cancer Treatment (PDQ®)

Learn about male breast cancer risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.
[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.